| Primary |
| Osteoporosis |
41.8% |
| Metastases To Bone |
12.2% |
| Breast Cancer |
11.7% |
| Bone Disorder |
5.6% |
| Bone Sarcoma |
5.1% |
| Osteoporosis Postmenopausal |
3.7% |
| Prostate Cancer |
2.9% |
| Prophylaxis |
2.7% |
| Multiple Myeloma |
2.1% |
| Pain |
2.1% |
| Neuroblastoma |
1.3% |
| Osteoarthritis |
1.3% |
| Cellulitis |
1.1% |
| Gastric Cancer |
1.1% |
| Metastatic Renal Cell Carcinoma |
1.1% |
| Myalgia |
1.1% |
| Analgesic Therapy |
0.8% |
| Hypertension |
0.8% |
| Renal Cancer |
0.8% |
| Thrombosis |
0.8% |
|
| Osteonecrosis Of Jaw |
21.6% |
| Death |
16.0% |
| Vomiting |
7.4% |
| Pyrexia |
6.2% |
| Surgery |
5.6% |
| Tooth Loss |
4.3% |
| Hip Fracture |
3.7% |
| Weight Decreased |
3.7% |
| Infection |
3.1% |
| Osteomyelitis Chronic |
3.1% |
| Osteonecrosis |
3.1% |
| Exposed Bone In Jaw |
2.5% |
| Oedema Peripheral |
2.5% |
| Oral Discomfort |
2.5% |
| Oral Pain |
2.5% |
| Pain |
2.5% |
| Pain In Extremity |
2.5% |
| Spinal Fracture |
2.5% |
| Syncope |
2.5% |
| Urinary Tract Infection |
2.5% |
|
| Secondary |
| Osteoporosis |
19.1% |
| Metastases To Bone |
14.5% |
| Breast Cancer |
10.5% |
| Bone Sarcoma |
7.9% |
| Multiple Myeloma |
7.9% |
| Prostate Cancer |
5.9% |
| Cellulitis |
5.3% |
| Analgesic Therapy |
3.9% |
| Pain |
3.9% |
| Gastric Cancer |
2.6% |
| Prophylaxis |
2.6% |
| Thrombosis |
2.6% |
| Vomiting |
2.6% |
| Osteoporosis Prophylaxis |
2.0% |
| Renal Cancer |
2.0% |
| Ascites |
1.3% |
| Hypertension |
1.3% |
| Infection |
1.3% |
| Metastatic Renal Cell Carcinoma |
1.3% |
| Non-small Cell Lung Cancer |
1.3% |
|
| Osteonecrosis Of Jaw |
23.3% |
| Pain |
7.0% |
| Vomiting |
7.0% |
| Asthenia |
4.7% |
| Bone Disorder |
4.7% |
| Creatinine Renal Clearance Decreased |
4.7% |
| Jaundice |
4.7% |
| Leukoencephalopathy |
4.7% |
| Osteomyelitis |
4.7% |
| Pyrexia |
4.7% |
| Soft Tissue Infection |
4.7% |
| Surgery |
4.7% |
| Weight Decreased |
4.7% |
| Affective Disorder |
2.3% |
| Ascites |
2.3% |
| Autoimmune Thrombocytopenia |
2.3% |
| Bladder Cancer |
2.3% |
| Cytolytic Hepatitis |
2.3% |
| Death |
2.3% |
| Decreased Appetite |
2.3% |
|
| Concomitant |
| Multiple Myeloma |
19.1% |
| Osteoporosis |
12.7% |
| Prophylaxis |
10.2% |
| Product Used For Unknown Indication |
7.6% |
| Constipation |
6.4% |
| Rheumatoid Arthritis |
6.4% |
| Thrombosis Prophylaxis |
4.5% |
| Plasma Cell Myeloma |
3.8% |
| Hypertension |
3.2% |
| Medical Diet |
3.2% |
| Neoplasm Malignant |
3.2% |
| Pain |
3.2% |
| Crohn's Disease |
2.5% |
| Prostate Cancer |
2.5% |
| Bone Pain |
1.9% |
| Breast Cancer |
1.9% |
| Breast Cancer Metastatic |
1.9% |
| Cancer Pain |
1.9% |
| Depression |
1.9% |
| Lung Adenocarcinoma Metastatic |
1.9% |
|
| Acute Myeloid Leukaemia |
6.9% |
| Aspiration |
6.9% |
| Bladder Cancer |
6.9% |
| Cholestasis |
6.9% |
| Cystitis Noninfective |
6.9% |
| Hyperbilirubinaemia |
6.9% |
| Implant Site Inflammation |
6.9% |
| Infection |
6.9% |
| Thrombocytopenia |
6.9% |
| Adenocarcinoma Of Colon |
3.4% |
| Asthenia |
3.4% |
| Blood Glucose Increased |
3.4% |
| Cardiac Disorder |
3.4% |
| Cardiac Failure |
3.4% |
| Cataract |
3.4% |
| Chromaturia |
3.4% |
| Coma |
3.4% |
| Disease Progression |
3.4% |
| Drug Ineffective |
3.4% |
| Emphysema |
3.4% |
|
